29-07-10 - Guerbet Global Results - mid year 2010 : Sustained revenue growth.
11-06-10 - Xenetix: Tolerance and efficacy in more than 324.000 patients : The new German post-marketing surveillance study (PMS) has been accepted in the European Journal of Radiology
11-05-10 - Dotarem study online in European Radiology : Korean study results performed on 92 patients now available.
Guerbet Asia Pacific, founded in 2000, is the Hong Kong branch of Guerbet Group from France.
Our first mission is to ensure the distribution of Guerbet contrast media to our Asian subsidiaries (Korea and Taiwan) and to 16 agents spread all over Asia and Oceania.
Our second mission is to support the commercial and marketing activities of these different agents.
See details
